Literature DB >> 23233711

Neoadjuvant treatment of a solitary melanoma brain metastasis with vemurafenib.

Grant R Kolar1, Michelle M Miller-Thomas, Robert E Schmidt, Joseph R Simpson, Keith M Rich, Gerald P Linette.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23233711     DOI： 10.1200/JCO.2012.43.7061

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  11 in total

1.  Radiation necrosis mimicking rapid intracranial progression of melanoma metastasis in two patients treated with vemurafenib.

Authors:  David A Liebner; Steven A Walston; Robert Cavaliere; Ciaran J Powers; Eric Sauvageau; Norman L Lehman; Hasel Wayne Slone; Meng Xu-Welliver; Fen Xia; Kari L Kendra
Journal:  Melanoma Res       Date:  2014-04       Impact factor: 3.599

2.  Rapid progression of intracranial melanoma metastases controlled with combined BRAF/MEK inhibition after discontinuation of therapy: a clinical challenge.

Authors:  Daniel N Cagney; Brian M Alexander; F Stephen Hodi; Elizabeth I Buchbinder; Patrick A Ott; Ayal A Aizer
Journal:  J Neurooncol       Date:  2016-07-11       Impact factor: 4.130

Review 3.  Advances in the management of low-grade gliomas.

Authors:  Amulya A Nageswara Rao; Roger J Packer
Journal:  Curr Oncol Rep       Date:  2014       Impact factor: 5.075

4.  Challenges in the delivery of therapies to melanoma brain metastases.

Authors:  Gautham Gampa; Shruthi Vaidhyanathan; Brynna-Wilken Resman; Karen E Parrish; Svetomir N Markovic; Jann N Sarkaria; William F Elmquist
Journal:  Curr Pharmacol Rep       Date:  2016-11-09

Review 5.  The Treatment of Melanoma Brain Metastases.

Authors:  Nour Kibbi; Harriet Kluger
Journal:  Curr Oncol Rep       Date:  2016-12       Impact factor: 5.075

Review 6.  Oral Targeted Therapies and Central Nervous System (CNS) Metastases.

Authors:  Michael P Gabay; Scott M Wirth; Joan M Stachnik; Colleen L Overley; Katie E Long; Linda R Bressler; John L Villano
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

7.  A new role of vemurafenib as a neoadjuvant treatment of axillary and brain melanoma metastases.

Authors:  Idit Melnik; Michal Lotem; Boris Yoffe
Journal:  Case Rep Oncol Med       Date:  2013-12-23

8.  In vitro treatment of melanoma brain metastasis by simultaneously targeting the MAPK and PI3K signaling pathways.

Authors:  Inderjit Daphu; Sindre Horn; Daniel Stieber; Jobin K Varughese; Endy Spriet; Hege Avsnes Dale; Kai Ove Skaftnesmo; Rolf Bjerkvig; Frits Thorsen
Journal:  Int J Mol Sci       Date:  2014-05-16       Impact factor: 5.923

9.  Neoadjuvant treatment of melanoma: case reports and review.

Authors:  Shachar Laks; Kevin A Brueske; Eddy C Hsueh
Journal:  Exp Hematol Oncol       Date:  2013-11-08

10.  Neoadjuvant therapy for locally advanced melanoma: new strategies with targeted therapies.

Authors:  Michele La Greca; Giuseppe Grasso; Giovanna Antonelli; Alessia Erika Russo; Salvatore Bartolotta; Alessandro D'Angelo; Felice Vito Vitale; Francesco Ferraù
Journal:  Onco Targets Ther       Date:  2014-06-19       Impact factor: 4.147
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.